Trials / Completed
CompletedNCT00894413
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine whether or not Cialis (tadalafil) administered to head and neck squamous cell cancer patients augments immune response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil | 20 mg once daily for 10 - 14 days |
| OTHER | Placebo Pill | Placebo |
Timeline
- Start date
- 2007-05-08
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2009-05-07
- Last updated
- 2019-06-11
- Results posted
- 2019-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00894413. Inclusion in this directory is not an endorsement.